RPL5 and neoplasm: Growth factor release by a supportive tumor microenvironment or other mechanisms such as tumor hypoxia, which cannot be mimicked in vitro, may explain why the RPL5 knockdown in MDA-MB-231 cells showed only a significant effect in the in vivo context.